Abstract
Prognostication occupies a central role in medical decision-making. An understanding of prognosis and relevant disease trajectory models is key for healthcare professionals caring for patients with progressive life-limiting conditions. It is a challenging aspect of professional practice for many, both because of its inexact nature and fears regarding the impact of prognostic disclosure. The research literature presented provides insight into the fallible nature of clinical predictions of survival and factors that may mitigate against this, including an understanding of prognostic indicators. Prognostic indicators including biomarkers and prognostic tools, which may be applied in advanced cancer and life-limiting nonmalignant conditions, are reviewed. Desire for prognostic information varies between individuals and within individuals over time; the outcomes of research studies that elicited the views and preferences of patients and bereaved relatives regarding prognostic disclosure are presented. The challenges inherent in diagnosing dying and key considerations are discussed, within the context of recent discontinuation of the Liverpool Care Pathway in the United Kingdom.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baba M, Maeda I, Morita T, et al. Survival prediction for advanced cancer patients in the real world: a comparison of the palliative prognostic score, delirium-palliative prognostic score, palliative prognostic index and modified prognosis in palliative care study predictor model. Eur J Cancer. 2015a;51:1618–29. https://doi.org/10.1016/j.ejca.2015.04.025.
Baba M, Maeda I, Morita T, et al. Independent validation of the modified prognosis palliative care study predictor models in three palliative care settings. J Pain Symptom Manag. 2015b;49:853–60. https://doi.org/10.1016/j.jpainsymman.2014.10.010.
Bhardwaj A, Januzzi JLJ. ST2: a novel biomarker for heart failure. Expert Rev Mol Diagn. 2010;10:459–64. https://doi.org/10.1586/erm.10.25.
Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148–59. https://doi.org/10.1056/NEJMra0800239.
Bruera E, Miller MJ, Kuehn N, et al. Estimated survival of patients admitted to a palliative care unit. J Pain Symptom Manag. 1992;7:82–6.
Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: a prospective cohort study. BMJ. 2000;320:469–73.
Desai AA, Nissenson A, Chertow GM, et al. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int. 2009;13:347–59. https://doi.org/10.1111/j.1542-4758.2009.00377.x.
Dolan RD, McSorley ST, Horgan PG, et al. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134–46. https://doi.org/10.1016/j.critrevonc.2017.06.002.
Downar J, Goldman R, Pinto R, et al. The “surprise question” for predicting death in seriously ill patients: a systematic review and meta-analysis. CMAJ. 2017;189:E484–93. https://doi.org/10.1503/cmaj.160775.
Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-Pugh versus MELD. J Hepatol. 2005;42(Suppl):S100–7. https://doi.org/10.1016/j.jhep.2004.11.015.
Enzinger AC, Zhang B, Schrag D, Prigerson HG. Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer. J Clin Oncol. 2015;33:3809–16. https://doi.org/10.1200/JCO.2015.61.9239.
Glare P, Virik K. Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manag. 2001;22:891–8. https://doi.org/10.1200/JCO.2005.06.866.
Glare P, Virik K, Jones M, et al. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ. 2003;327:195.
Gripp S, Moeller S, Bolke E, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25:3313–20. https://doi.org/10.1200/JCO.2006.10.5411.
Gwilliam B, Keeley V, Todd C, et al. Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study. BMJ. 2011;343:d4920. https://doi.org/10.1136/bmj.d4920.
Gwilliam B, Keeley V, Todd C, et al. Prognosticating in patients with advanced cancer – observational study comparing the accuracy of clinicians“ and patients” estimates of survival. Ann Oncol. 2013;24:482–8. https://doi.org/10.1093/annonc/mds341.
Haga K, Murray S, Reid J, et al. Identifying community based chronic heart failure patients in the last year of life: a comparison of the Gold Standards Framework Prognostic Indicator Guide and the Seattle Heart Failure Model. Heart. 2012;98:7:579. https://doi.org/10.1136/heartjnl-2011-301021
Hagerty RG, Butow PN, Ellis PM, et al. Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol. 2005;16:1005–53. https://doi.org/10.1093/annonc/mdi211.
Hauser C, Stockler M, Tattersall M. Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer. 2006;14:999–1011.
Huang Y-T, Tseng Y-T, Chu T-W, et al. N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure. Sci Rep. 2016;6:29590. https://doi.org/10.1038/srep29590.
Iwase S, Murakami T, Saito Y, Nakagawa K. Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients. Eur Cytokine Netw. 2004;15:312–6.
Kennedy C, Brooks-Young P, Brunton Gray C, et al. Diagnosing dying: an integrative literature review. BMJ Support Palliat Care. 2014;4:263–70. https://doi.org/10.1136/bmjspcare-2013-000621.
Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19:105–15. https://doi.org/10.3350/cmh.2013.19.2.105.
Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018–26. https://doi.org/10.1056/NEJMoa0801209.
Kirkwood B, Sterne J. Essential medical statistics. Hoboken: Wiley; 2003.
Krawczyk M, Gallagher R. Communicating prognostic uncertainty in potential end-of-life contexts: experiences of family members. BMC Palliat Care. 2016;15:59. https://doi.org/10.1186/s12904-016-0133-4.
Leadership Alliance for the Care of Dying People. One chance to get it right. Department of Health and Social Care. 2014. Publications Gateway Reference 01509.
Ling Q, Dai H, Zhuang R, et al. Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry. Sci Rep. 2017;7:42253. https://doi.org/10.1038/srep42253.
Maltoni M, Nanni O, Derni S, et al. Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients. Eur J Cancer. 1994;30A:764–6.
Maltoni M, Nanni O, Pirovano M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage. 1999;17:240–7.
Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23:6240–8.
Mendis R, Soo W-K, Zannino D, et al. Multidisciplinary prognostication using the palliative prognostic score in an Australian Cancer Center. Palliat Care. 2015;9:7–14.
Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med. 2009;361:1529–38. https://doi.org/10.1056/NEJMoa0902234.
Mitchell SL, Miller SC, Teno JM, et al. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA. 2010;304:1929–35.
Morita T, Tsunoda J, Inoue S, Chihara S. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7:128–33.
Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ. 2005;330:1007–11.
Murtagh FEM, Preston M, Higginson I. Patterns of dying: palliative care for non-malignant disease. Clin Med. 2004;4:39–44.
National Clinical Guideline Centre. Care of dying adults in the last days of life. London: National Institute for Health and Care Excellence (UK); 2015.
Neuberger J, Guthrie C, Aaronovitch D. More care, less pathway: a review of the Liverpool Care Pathway. Department of Health and Social Care 2013.
Oxenham D, Cornbleet MA. Accuracy of prediction of survival by different professional groups in a hospice. Palliat Med. 1998;12:117–8. https://doi.org/10.1191/026921698672034203.
Parkes CM. Accuracy of predictions of survival in later stages of cancer. BMJ. 1972;2:29–31.
Pautex S, Vayne-Bossert P, Jamme S, et al. Anatomopathological causes of death in patients with advanced cancer: association with the use of anticoagulation and antibiotics at the end of life. J Palliat Med. 2013;16:669–74. https://doi.org/10.1089/jpm.2012.0369.
Pontin D, Jordan N. Issues in prognostication for hospital specialist palliative care doctors and nurses: a qualitative inquiry. Palliat Med. 2013;27:165–71. https://doi.org/10.1177/0269216311432898.
Reid VL, McDonald R, Nwosu AC, et al. A systematically structured review of biomarkers of dying in cancer patients in the last months of life; an exploration of the biology of dying. PLoS One. 2017;12:e0175123.
Reindl-Schwaighofer R, Kainz A, Kammer M, et al. Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5. PLoS One. 2017;12:e0181345.
Shin H-S, Lee H-R, Lee D-C, et al. Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients. J Pain Symptom Manag. 2006;31:493–501. https://doi.org/10.1016/j.jpainsymman.2005.11.014.
Smith L-JE, Moore E, Ali I, et al. Prognostic variables and scores identifying the end of life in COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:2239–56.
Stone CA, Tiernan E, Dooley BA. Prospective validation of the palliative prognostic index in palliative care patients. J Pain Symptom Manag. 2008;35:617-622. https://doi.org/10.1016/j.jpainsymman.2007.07.006.
Twomey F, O’Leary N, O’Brien T. Prediction of patient survival by healthcare professionals in a specialist palliative care inpatient unit: a prospective study. Am J Hosp Palliat Care. 2008;25:139–45. https://doi.org/10.1177/1049909107312594.
Vigano A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999;86:170–6.
Warraich HJ, Allen LA, Mukamal KJ, et al. Accuracy of physician prognosis in heart failure and lung cancer: comparison between physician estimates and model predicted survival. Palliat Med. 2016;30:684–9. https://doi.org/10.1177/0269216315626048.
White N, Reid F, Harris A, et al. A systematic review of predictions of survival in palliative care: how accurate are clinicians and who are the experts? 2016.
White N, Kupeli N, Vickerstaff V, Stone P. How accurate is the “surprise question” at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med. 2017;15:139.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Stone, C.A., Campbell, R., Grimes, S. (2019). Prognostication in Palliative Care. In: MacLeod, R., Van den Block, L. (eds) Textbook of Palliative Care. Springer, Cham. https://doi.org/10.1007/978-3-319-77740-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-77740-5_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77738-2
Online ISBN: 978-3-319-77740-5
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences